This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chongqing Upgra Biotechnology Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Zhaojie Wang: Innovator in Polyethylene Glycol Conjugate Drugs
Introduction
Zhaojie Wang is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of medicine, particularly in the development of polyethylene glycol conjugated drugs. His innovative work has the potential to enhance drug delivery and efficacy.
Latest Patents
Zhaojie Wang holds a patent for a polyethylene glycol conjugate drug, along with its preparation method and uses. This invention relates to the technical field of medicines and specifically addresses the formulation of a polyethylene glycol conjugated drug, as well as its pharmaceutically acceptable salts. The patent outlines a method for preparing the drug and its applications in pharmaceutical compositions.
Career Highlights
Zhaojie Wang is associated with Chongqing Upgra Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options through innovative drug formulations.
Collaborations
Zhaojie Wang collaborates with notable colleagues, including Gaoquan Li and Dajun Li, who contribute to his research endeavors and help drive forward the development of new medicinal technologies.
Conclusion
Zhaojie Wang's contributions to the field of polyethylene glycol conjugated drugs exemplify the impact of innovation in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care through enhanced drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile